Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug

Sunshine Biopharma Inc. (NASDAQ:SBFM) traded higher on Wednesday, with a session volume of 19.07 million compared to an average volume of 88.16K, according to data from Benzinga Pro.

The company on Wednesday announced that it has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid Nanoparticle (K1.1-mRNA-LNP) product as a therapeutic agent for human hepatocellular carcinoma.

Human hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and the most common type of primary liver cancer in adults.

The company optimized the expression level of its full-length ...

https://www.benzinga.com/25/04/44609792/nano-cap-sunshine-biopharma-stock-shoots-higher-on-encouraging-preclinical-data-from-potential-mrna-based-liver-c